Phase 1 study of Lonafarnib (SCH 66336) and imatinib mesylate in patients with chronic myeloid leukemia who have failed prior single-agent therapy with imatinib

Jorge Cortes, Elias Jabbour, George Q. Daley, Susan O'Brien, Srdan Verstovsek, Alessandra Ferrajoli, Charles Koller, Yali Zhu, Paul Statkevich, Hagop Kantarjian

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1 study of Lonafarnib (SCH 66336) and imatinib mesylate in patients with chronic myeloid leukemia who have failed prior single-agent therapy with imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences